National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Carcinoma of Unknown Primary Treatment (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 06/13/2008



Description






Stage Explanation






Treatment Option Overview






Newly Diagnosed Carcinoma of Unknown Primary






Recurrent Carcinoma of Unknown Primary






To Learn More About Carcinoma of Unknown Primary






Get More Information From NCI






Changes to This Summary (06/13/2008)






About PDQ



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
The Cancer Genome Atlas Reports Brain Tumors Study

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Recurrent Carcinoma of Unknown Primary

Treatment of recurrent CUP depends on the type of cancer, what treatment was received before, the part of the body where the cancer has come back, and other factors. A patient may want to consider taking part in a clinical trial.

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with recurrent carcinoma of unknown primary.

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov